These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16275074)

  • 1. Metalloantimalarials: synthesis, X-ray crystal structure of potent antimalarial copper (II) complex of arylazo-4-hydroxy-1,2-naphthoquinone.
    Gokhale NH; Shirisha K; Padhye SB; Croft SL; Kendrick HD; Mckee V
    Bioorg Med Chem Lett; 2006 Jan; 16(2):430-2. PubMed ID: 16275074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structures and anti-malaria activity of some gold(I) phosphine complexes containing seleno- and thiosemicarbazonato ligands.
    Molter A; Rust J; Lehmann CW; Deepa G; Chiba P; Mohr F
    Dalton Trans; 2011 Oct; 40(38):9810-20. PubMed ID: 21879088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel ferrocene-naphthoquinones as antiplasmodial agents.
    García-Barrantes PM; Lamoureux GV; Pérez AL; García-Sánchez RN; Martínez AR; San Feliciano A
    Eur J Med Chem; 2013; 70():548-57. PubMed ID: 24211630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloantimalarials: synthesis and characterization of a novel agent possessing activity against Plasmodium falciparum.
    Ocheskey JA; Harpstrite SE; Oksman A; Goldberg DE; Sharma V
    Chem Commun (Camb); 2005 Mar; (12):1622-4. PubMed ID: 15770280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents.
    Kongkathip N; Pradidphol N; Hasitapan K; Grigg R; Kao WC; Hunte C; Fisher N; Warman AJ; Biagini GA; Kongsaeree P; Chuawong P; Kongkathip B
    J Med Chem; 2010 Feb; 53(3):1211-21. PubMed ID: 20067272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
    J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
    Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
    Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
    Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
    Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
    Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum.
    Gokhale NH; Padhye SB; Croft SL; Kendrick HD; Davies W; Anson CE; Powell AK
    J Inorg Biochem; 2003 Jul; 95(4):249-58. PubMed ID: 12818795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands.
    Hemmert C; Fabié A; Fabre A; Benoit-Vical F; Gornitzka H
    Eur J Med Chem; 2013 Feb; 60():64-75. PubMed ID: 23287052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel N-heterocyclic ylideneamine gold(I) complexes: synthesis, characterisation and screening for antitumour and antimalarial activity.
    Coetzee J; Cronje S; Dobrzańska L; Raubenheimer HG; Jooné G; Nell MJ; Hoppe HC
    Dalton Trans; 2011 Feb; 40(7):1471-83. PubMed ID: 21225079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
    Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
    J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites.
    Müller T; Johann L; Jannack B; Brückner M; Lanfranchi DA; Bauer H; Sanchez C; Yardley V; Deregnaucourt C; Schrével J; Lanzer M; Schirmer RH; Davioud-Charvet E
    J Am Chem Soc; 2011 Aug; 133(30):11557-71. PubMed ID: 21682307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
    Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
    J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally restrained aromatic analogues of fosmidomycin and FR900098.
    Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD
    Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.